Temat: "Proton Pump Inhibitors" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Potential proton pump inhibitor-related adverse effects.
Autorzy :: Perry IE; Division of Gastroenterology and Hepatology, Augusta University-Medical College of Georgia, Augusta, Georgia.
Sonu I; Division of Gastroenterology and Hepatology, Stanford University, Redwood City, California.
Scarpignato C; Department of Health Sciences, United Campus of Malta, Msida, Malta.; Faculty of Medicine, Chinese University of Hong Kong, ShaTin, Hong Kong.
Akiyama J; Division of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Hongo M; Department of Comprehensive Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan.; Department of Medicine, Kurokawa General Hospital, Kurokawa, Miyagi, Japan.
Vega KJ; Division of Gastroenterology and Hepatology, Augusta University-Medical College of Georgia, Augusta, Georgia.; Pokaż więcej
Źródło :: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2020 Dec; Vol. 1481 (1), pp. 43-58. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Proton Pump Inhibitors*/adverse effects
Proton Pump Inhibitors*/therapeutic use
Dementia/*chemically induced
Gastrointestinal Microbiome/*drug effects
Osteoporosis/*chemically induced
Dementia/therapy ; Drug Interactions ; Gastroesophageal Reflux/drug therapy ; Helicobacter Infections/drug therapy ; Helicobacter pylori ; Humans ; Neoplasms/drug therapy ; Osteoporosis/therapy ; Peptic Ulcer/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Autorzy :: Lee SW; Department of Data Science, Sejong University College of Software Convergence, Seoul, Korea .
Ha EK; Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Yeniova AÖ; Division of Gastroenterology, Department of Internal Medicine, Tokat Gaziosmanpaşa University Faculty of Medicine, Tokat, Turkey.
Moon SY; Department of Data Science, Sejong University College of Software Convergence, Seoul, Korea.
Kim SY; Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Koh HY; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yang JM; Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jeong SJ; Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Moon SJ; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho JY; Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Yoo IK; Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea .
Yon DK; Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea .; Armed Force Medical Command, Republic of Korea Armed Forces, Seongnam, Korea.; Pokaż więcej
Źródło :: Gut [Gut] 2021 Jan; Vol. 70 (1), pp. 76-84. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*/complications
COVID-19*/mortality
COVID-19*/therapy
COVID-19 Testing*/methods
COVID-19 Testing*/statistics & numerical data
Proton Pump Inhibitors*/administration & dosage
Proton Pump Inhibitors*/adverse effects
Stomach Diseases*/drug therapy
Stomach Diseases*/epidemiology
Intensive Care Units/*statistics & numerical data
Respiration, Artificial/*statistics & numerical data
Cause of Death ; Comorbidity ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Outcome and Process Assessment, Health Care ; Republic of Korea/epidemiology ; SARS-CoV-2/isolation & purification ; Severity of Illness Index
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Gastrointestinal pharmacology: practical tips for the esophagologist.
Autorzy :: Scarpignato C; Department of Health Sciences, United Campus of Malta, Msida, Malta.; Faculty of Medicine, Chinese University of Hong Kong, ShaTin, Hong Kong.
Sloan JA; Division of Gastroenterology and Hepatology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Wang DH; Division of Hematology and Oncology, UT Southwestern Medical Center and VA North Texas Health Care System, Dallas, Texas.
Hunt RH; Division of Gastroenterology, Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.; Pokaż więcej
Źródło :: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2020 Dec; Vol. 1481 (1), pp. 90-107. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Proton Pump Inhibitors*/adverse effects
Proton Pump Inhibitors*/therapeutic use
Barrett Esophagus/*drug therapy
Drug Resistance, Neoplasm/*drug effects
Esophageal Neoplasms/*drug therapy
Gastroesophageal Reflux/*drug therapy
Gastrointestinal Motility/*drug effects
Barrett Esophagus/metabolism ; Esophageal Mucosa/metabolism ; Esophageal Mucosa/pathology ; Esophageal Neoplasms/metabolism ; Gastroesophageal Reflux/metabolism ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Autorzy :: Chen LY; Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.; School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan.
Lin HJ; Department of Neurology, Chi-Mei Medical Center, Tainan City 710, Taiwan.
Wu WT; Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.; School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan.
Chen YC; Department of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.; Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.
Chen CL; School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan.
Kao J; School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan.
You SL; Department of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.; Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.
Chou YC; School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan.
Sun CA; Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.; Department of Public Health, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Nov 09; Vol. 17 (21). Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dementia*/chemically induced
Dementia*/epidemiology
Histamine H2 Antagonists*/adverse effects
Proton Pump Inhibitors*/adverse effects
Aged ; Cohort Studies ; Female ; Humans ; Male ; Proportional Hazards Models ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril.
Autorzy :: Mostafa DK; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Electronic address: .
Khedr MM; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Barakat MK; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abdellatif AA; Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Elsharkawy AM; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2021 Jan 15; Vol. 265, pp. 118818. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :: Journal Article
MeSH Terms :: Autophagy/*drug effects
Diabetes Mellitus, Experimental/*complications
Diabetic Nephropathies/*physiopathology
Lansoprazole/*toxicity
Proton Pump Inhibitors/*toxicity
Albuminuria/etiology ; Animals ; Diabetic Nephropathies/prevention & control ; Diet, High-Fat ; Enalapril/pharmacology ; Lansoprazole/administration & dosage ; Male ; Metformin/pharmacology ; Mice ; Oxidative Stress/drug effects ; Proton Pump Inhibitors/administration & dosage ; Streptozocin
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology?
Autorzy :: Conrad KP; Departments of Physiology and Functional Genomics, and of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, FL, USA.; Pokaż więcej
Źródło :: Physiological reports [Physiol Rep] 2021 Jan; Vol. 8 (24), pp. e14649.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Virus Internalization*
COVID-19/*drug therapy
Proton Pump Inhibitors/*therapeutic use
Proton Pumps/*metabolism
Sodium-Hydrogen Exchangers/*antagonists & inhibitors
Animals ; COVID-19/virology ; Humans ; Proton Pump Inhibitors/pharmacology ; SARS-CoV-2/drug effects ; SARS-CoV-2/physiology ; Sodium-Hydrogen Exchangers/metabolism
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?
Autorzy :: Luxenburger H; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.; IMM-PACT, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sturm L; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Biever P; Department of Medicine III (Interdisciplinary Medical Intensive Care), Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Rieg S; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Duerschmied D; Department of Medicine III (Interdisciplinary Medical Intensive Care), Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Schultheiss M; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Neumann-Haefelin C; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Thimme R; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Bettinger D; From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Pokaż więcej
Źródło :: Journal of internal medicine [J Intern Med] 2021 Jan; Vol. 289 (1), pp. 121-124. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :: Letter
MeSH Terms :: Inpatients*
SARS-CoV-2*
COVID-19/*drug therapy
Coinfection/*etiology
Proton Pump Inhibitors/*adverse effects
Aged ; COVID-19/epidemiology ; Coinfection/epidemiology ; Female ; Global Health ; Humans ; Male ; Middle Aged ; Pandemics ; Proton Pump Inhibitors/therapeutic use ; Risk Factors
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank.
Autorzy :: Fan X; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Liu Z; Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Miyata T; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.
Dasarathy S; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio; Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio.
Rotroff DM; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Wu X; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.
Poulsen KL; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.
Nagy LE; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio; Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio. Electronic address: .; Pokaż więcej
Źródło :: Gastroenterology [Gastroenterology] 2021 Jan; Vol. 160 (1), pp. 455-458.e5. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19/*epidemiology
Histamine H2 Antagonists/*therapeutic use
Proton Pump Inhibitors/*therapeutic use
Adult ; Aged ; COVID-19/diagnosis ; COVID-19/mortality ; Female ; Histamine H2 Antagonists/adverse effects ; Humans ; Male ; Middle Aged ; Prevalence ; Prognosis ; Propensity Score ; Proton Pump Inhibitors/adverse effects ; Risk Assessment ; Risk Factors ; Time Factors ; United Kingdom/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis.
Autorzy :: Liu X; Gansu University of Chinese Medicine.; Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu province.
Jiang Y; Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu province.
Luo H; Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu province.
Liu H; Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 04; Vol. 99 (49), pp. e23297.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Gastrointestinal Agents/*therapeutic use
Laryngopharyngeal Reflux/*drug therapy
Proton Pump Inhibitors/*therapeutic use
Gastrointestinal Agents/adverse effects ; Humans ; Proton Pump Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Research Design
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.
Autorzy :: Singh-Franco D; Department of Pharmacy Practice, Nova Southeastern University, College of Pharmacy, Fort Lauderdale, Florida, United States of America.
Mastropietro DR; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, Florida, United States of America.
Metzner M; Department of Pharmacy Practice, Nova Southeastern University, College of Pharmacy, Fort Lauderdale, Florida, United States of America.
Dressler MD; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, Florida, United States of America.
Fares A; Department of Pharmacy Practice, Nova Southeastern University, College of Pharmacy, Fort Lauderdale, Florida, United States of America.
Johnson M; Martin and Gail Press Health Professions Division Library, Nova Southeastern University, Fort Lauderdale, Florida, United States of America.
De La Rosa D; Martin and Gail Press Health Professions Division Library, Nova Southeastern University, Fort Lauderdale, Florida, United States of America.
Wolowich WR; Department of Pharmacy Practice, Nova Southeastern University, College of Pharmacy, Fort Lauderdale, Florida, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Dec 03; Vol. 15 (12), pp. e0243134. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Antacids/*therapeutic use
Anti-Ulcer Agents/*therapeutic use
Proton Pump Inhibitors/*therapeutic use
Antacids/adverse effects ; Anti-Ulcer Agents/adverse effects ; Humans ; Intensive Care Units ; Patient Discharge ; Pharmacies ; Pharmacists ; Proton Pump Inhibitors/adverse effects
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Autorzy :: Wu CL; Department of Psychiatry, Taipei Veterans General Hospital, Hualien City, Taiwan.; Institute of Medical Sciences, Tzu Chi University, Hualien City, Taiwan.
Lei WY; Institute of Medical Sciences, Tzu Chi University, Hualien City, Taiwan.; Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien City, Taiwan.
Wang JS; Department of Psychiatry, Taipei Veterans General Hospital, Hualien City, Taiwan.
Lin CE; Department of Psychiatry, Taipei Tzu Chi Hospital, New Taipei City, Taiwan.; School of Medicine, Tzu Chi University, Hualien City, Taiwan.
Chen CL; Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien City, Taiwan.
Wen SH; Institute of Medical Sciences, Tzu Chi University, Hualien City, Taiwan.; Department of Public Health, College of Medicine, Tzu Chi University, Hualien City, Taiwan.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 30; Vol. 15 (11), pp. e0242975. Date of Electronic Publication: 2020 Nov 30 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dementia/*epidemiology
Histamine H2 Antagonists/*adverse effects
Proton Pump Inhibitors/*adverse effects
Adult ; Aged ; Cohort Studies ; Dementia/chemically induced ; Dementia/pathology ; Female ; Histamine H2 Antagonists/therapeutic use ; Humans ; Male ; Middle Aged ; Propensity Score ; Proportional Hazards Models ; Proton Pump Inhibitors/therapeutic use ; Risk Factors ; Taiwan/epidemiology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis.
Autorzy :: Lin M; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.; Sichuan Acupuncture School, Chengdu.
Zhang S; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macao.
Zhang M; Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai.
Shi J; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.
Zhang C; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.
Luo R; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.
You J; School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou.
Sun J; Innovative Institute of Chinese of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zhang J; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.
Gao F; Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China and Pharmacy School, Chengdu University of Traditional Chinese Medicine.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Nov 25; Vol. 99 (48), pp. e23103.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Materia Medica/*therapeutic use
Peptic Ulcer/*drug therapy
Proton Pump Inhibitors/*therapeutic use
Rabeprazole/*therapeutic use
Drug Therapy, Combination ; Humans ; Materia Medica/administration & dosage ; Proton Pump Inhibitors/administration & dosage ; Rabeprazole/administration & dosage ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
Autorzy :: Mizokami Y; Department of Gastroenterology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
Yamamoto T; Department of Medicine, Teikyo University, Itabashi City, Tokyo, Japan.
Atarashi H; Minami Hachioji Hospital, Hachioji, Tokyo, Japan.
Yamashita T; The Cardiovascular Research Institute, Minato City, Tokyo, Japan.
Akao M; National Hospital Organization Kyoto Medical Center, Fushimi Ward, Kyoto, Japan.
Ikeda T; Toho University Omori Medical Center, Ota City, Tokyo, Japan.
Koretsune Y; National Hospital Organization Osaka National Hospital, Chuo Ward, Osaka, Japan.
Okumura K; Saiseikai Kumamoto Hospital, Minami Ward, Kumamoto, Japan.
Shimizu W; Nippon Medical School, Bunkyo City, Tokyo, Japan.
Tsutsui H; Kyushu University, Higashi Ward, Fukuoka, Japan.
Toyoda K; National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hirayama A; Osaka Police Hospital, Tennoji Ward, Osaka, Japan.
Yasaka M; National Hospital Organization Kyushu Medical Center, Chuo Ward, Fukuoka, Japan.
Yamaguchi T; National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Teramukai S; Kyoto Prefectural University of Medicine, Kamigyo Ward, Kyoto, Japan.
Kimura T; Medical Science Department, Daiichi Sankyo Co., Ltd., Chuo City, Tokyo, Japan.
Kaburagi J; Medical Science Department, Daiichi Sankyo Co., Ltd., Chuo City, Tokyo, Japan.
Takita A; Biostatistics and Data Management Department, Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan.
Inoue H; Saiseikai Toyama Hospital, Toyama, Toyama, Japan.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 05; Vol. 15 (11), pp. e0240859. Date of Electronic Publication: 2020 Nov 05 (Print Publication: 2020).
Typ publikacji :: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Atrial Fibrillation/*drug therapy
Proton Pump Inhibitors/*therapeutic use
Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Atrial Fibrillation/complications ; Cohort Studies ; Drug Therapy, Combination ; Female ; Hemorrhage/epidemiology ; Hemorrhage/etiology ; Hemorrhage/prevention & control ; Humans ; Japan/epidemiology ; Male ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/therapeutic use ; Prospective Studies ; Proton Pump Inhibitors/administration & dosage ; Registries ; Risk Factors ; Stroke/epidemiology ; Stroke/etiology ; Stroke/prevention & control
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
Autorzy :: Boushey H; Emeritus Professor of Medicine, UCSF, San Francisco, California, USA.
Gonda I; Respidex LLC, Dennis, Massachusetts, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1921.
Typ publikacji :: Letter; Comment
MeSH Terms :: Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
Betacoronavirus ; COVID-19 ; Humans ; Risk Factors ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
Autorzy :: Aby ES; Division of Gastroenterology & Hepatology, Hennepin Healthcare, Minneapolis, Minnesota, USA.; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Rodin H; Analytic Center of Excellence, Hennepin County Medical Center, Minneapolis, Minnesota, USA.
Debes JD; Division of Gastroenterology & Hepatology, Hennepin Healthcare, Minneapolis, Minnesota, USA.; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1918.
Typ publikacji :: Letter; Comment
MeSH Terms :: Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
Betacoronavirus ; COVID-19 ; Gastric Acid ; Humans ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Regarding "Increased Risk of COVID-19 in Patients Taking Proton Pump Inhibitors".
Autorzy :: Hajifathalian K; Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York, USA.
Katz PO; Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1918-1919.
Typ publikacji :: Letter; Comment
MeSH Terms :: Betacoronavirus*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
COVID-19 ; Humans ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
Autorzy :: Tarlow B; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California, USA.
Gubatan J; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California, USA.
Khan MA; Division of Gastroenterology and Hepatology, University of Alabama, Birmingham, Alabama, USA.
Cholankeril G; Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1920-1921.
Typ publikacji :: Letter; Comment
MeSH Terms :: Betacoronavirus*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
COVID-19 ; Humans ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
Autorzy :: Hadi YB; Section of Gastroenterology and Hepatology, Department of Medicine, West Virginia University, Morgantown, West Virginia, USA.
Naqvi SF; Section of Pulmonary and Critical Care Medicine, Department of Medicine, West Virginia University, Morgantown, West Virginia, USA.
Kupec JT; Section of Gastroenterology and Hepatology, Department of Medicine, West Virginia University, Morgantown, West Virginia, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1919-1920.
Typ publikacji :: Letter; Comment
MeSH Terms :: Betacoronavirus*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
COVID-19 ; Humans ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
Autorzy :: Almario CV; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Karsh Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, California, USA.; Division of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Division of Informatics, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Chey WD; Department of Medicine, Michigan Medicine, Ann Arbor, Michigan, USA.; Division of Gastroenterology, Michigan Medicine, Ann Arbor, Michigan, USA.
Spiegel BMR; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Karsh Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, California, USA.; Division of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, California, USA.; Pokaż więcej
Źródło :: The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1922-1923.
Typ publikacji :: Letter; Comment
MeSH Terms :: Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors*/adverse effects
Betacoronavirus ; COVID-19 ; Humans ; Risk Factors ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Binding of omeprazole to protein targets identified by monoclonal antibodies.
Autorzy :: Cartee NMP; Department of Neurology, University of Michigan, Ann Arbor, MI, United States of America.; Department of Veterans Affairs, Neurology Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, United States of America.
Wang MM; Department of Neurology, University of Michigan, Ann Arbor, MI, United States of America.; Department of Veterans Affairs, Neurology Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, United States of America.; Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Sep 18; Vol. 15 (9), pp. e0239464. Date of Electronic Publication: 2020 Sep 18 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Antibodies, Monoclonal, Murine-Derived/*metabolism
Omeprazole/*immunology
Omeprazole/*metabolism
Proton Pump Inhibitors/*immunology
Proton Pump Inhibitors/*metabolism
Animals ; Binding Sites ; Cysteine/chemistry ; HEK293 Cells ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Multiprotein Complexes/chemistry ; Multiprotein Complexes/metabolism ; Omeprazole/chemistry ; Protein Binding ; Proton Pump Inhibitors/chemistry
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Proton Pump Inhibitors"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język